Surgical Treatment for Postparalytic Facial Synkinesis: A 35-Year Experience

Plast Reconstr Surg. 2022 Sep 1;150(3):631-643. doi: 10.1097/PRS.0000000000009484. Epub 2022 Jul 1.

Abstract

Background: Surgical intervention with combined myectomy and neurectomy followed by functioning free muscle transplantation has been proposed to effectively resolve the problem of postparalytic facial synkinesis since 1985, and it continues to be the authors' standard of care. The authors aim to provide evidence that this surgical strategy is effective for treatment of synkinesis and smile quality.

Methods: One hundred three patients with postparalytic facial synkinesis were investigated (1985 to 2020). They all underwent extensive removal of the synkinetic muscles and triggered facial nerve branches in the cheek, nose, and neck regions, followed by gracilis functioning free muscle transplantation for facial reanimation. Ninety-four patients (50 with type II and 44 with type III postparalytic facial synkinesis), all of whom had at least 1 year of postoperative follow-up, were included in the study. Patient demographics and functional and aesthetic evaluations before and after surgery were collected.

Results: In the yearly distribution of the facial paralysis reconstruction, the incidence of surgical intervention increased from 15 percent before 2012 up to 24 percent in the years after. Young adults (79 percent) and female patients (63 percent) were the dominant population. Results showed a significant improvement of the facial smile quality, with more teeth visible while smiling, and a long-lasting decrease of facial synkinesis. Ninety-six percent of patients did not require botulinum toxin type A injection after surgery. Revision surgery for secondary deformity was 53 percent.

Conclusions: Combined myectomy and neurectomy followed by functioning free muscle transplantation for type II and III synkinetic patients leads to promising and long-lasting results despite high revision rates. Refined techniques to decrease the revision rates are needed in the future.

Clinical question/level of evidence: Therapeutic, IV.

MeSH terms

  • Botulinum Toxins, Type A* / therapeutic use
  • Facial Muscles / innervation
  • Facial Nerve / surgery
  • Facial Paralysis*
  • Female
  • Humans
  • Retrospective Studies
  • Smiling
  • Synkinesis* / drug therapy
  • Synkinesis* / etiology
  • Synkinesis* / surgery
  • Young Adult

Substances

  • Botulinum Toxins, Type A